Study on the simultaneous presence of dermatomycoses and diabetes in patients living in a rural area from a municipality in the Paraná State
DOI:
https://doi.org/10.33448/rsd-v10i9.17781Keywords:
Dermatomycoses; Diabetes mellitus; Onychomycosis.Abstract
Diabetes mellitus is a predisposing factor for dermatomycosis, despite it is not yet completely understood, especially in regards to those living in rural areas. Objective: To evaluate the occurrence of dermatomycosis in diabetics, aged over 60 years old, living in the rural area of Ivatuba, Paraná, Brazil. Methods: Patients of HiperDia program answered a questionnaire and provided blood samples, and cutaneous lesions scraped, for laboratory investigation. Results: forty-five individuals were included in the study, of which 37 had cutaneous lesions and were investigated in the laboratory. Fungi were detected in 17 of them (45.9%), with dermatophytes being the most frequent agents. There was no significant difference in the assessed metabolic parameters of individuals with and without mycosis, nor in terms of rural life habits, however some fungi sampled were resistant to phagocytosis and especially to death by phagocytes from diabetic animals. Conclusion: A high rate of dermatomycosis was detected in individuals with diabetes, probably related to the failure in the activation of phagocytes.
References
Akkus, G., Evran, M., Gungor, D., Karakas, M., Sert, M. & Tetiker, T. (2016). Tinea pedis and onychomycosis frequency in diabetes mellitus patients and diabetic foot ulcers. A cross sectional – observational study. Pak J Med Sci, 32:891-895.
Assadamongkol, R., Lertwattanarak, R., Wannachalee, T., Bunyaratavej, S., Leeyaphan, C. & Matthapan L. (2016). Prevalence, risk factors, and type of organism in fungal foot infection and toenail onychomycosis in Thai diabetic patients. J Med Assoc Thai, 99:659-664.
Babayani, M., Salari, S., Hashemi, S.J., Ghasemi, N.A.P. & Fattahi, A. (2018). Onychomycosis due to dermatophytes species in Iran: Prevalence rates, causative agents, predisposing factors and diagnosis based on microscopic morphometric findings. J Mycol Med, 28:45-50.
Basu, S., Yudkin, J.S., Kehlenbrink, S., Davies, J., Wild, S.H., Lipska, K.J., et al. (2018). Estimation of global insulin utilization for Type 2 Diabetes Mellitus, 2018 to 2030: A Microsimulation Model (2018). Lancet Diabetes Endocrinol, 7(1):22-33.
Busui, R., Pop, B.A.J., Feldman, E.L., Bril, V., Freeman, R., Malik, R.A., et al. (2017). Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care, 40:136-154.
Casagranda, L.P., Lange, C., Zillmer, J.G.V., dos Santos F., Castro, D.S.P. & de Llano, P.M.P. (2018). Prevalência de Diabetes Mellitus em idosos da zona rural no Sul do Brasil. Enfermagem Brasil, 17(4): 09-28.
Cho, N.H., Shaw, J.E., Karuranga, S., Huang, Y., da Rocha Fernandes, J.D, Ohlrogge, A.W. & Malanda, B. (2018). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract, 138:271-81.
Da Costa, M.L., Moraes, R.B., Vaz, D.W.N., dos Santos, G.A., Duarte, R.C. da C., dos Santos Jr, J.A.B., Menezes, T.X.F. & Teixeira, R.S. (2021). Avaliação dos pacientes com Diabetes e Hipertensão em uma Estratégia de Saúde da Família localizada na zona rural do interior do Estado do Pará. Res, Soc Dev, 10(3).
Dahlke RJ, Botelho TKR, Loch AP, & de Cordova, CMM. (2015). Micoses superficiais em pacientes com diabetes mellitus atendidos em um ambulatório geral em Blumenau, SC. Rev Bras Anal Clin, 47:170-3
Da Silva, E.F., Paniz, V.M.V., Laste, G., Torres, I.L. da S. (2013). Prevalência de morbidade e sintomas em idosos: um estudo comparativo entre as áreas rural e urbana. Ciênc. saúde coletiva, 18:1029-40.
Da Silva, R.M.P.R., Nunes e Silva, V.R. & Paz, F.A. do N. (2021). Ações de enfermagem junto aos portadores de diabetes mellitus residentes da zona rural. Res, Soc Dev, 10(6).
De Zuani, M., Paolicelli, G., Zelante, T., Renga, G., Romani, L., Arzese, A., Pucillo, C.E.M. & Frossi, B. (2018). Mast cells respond to Candida albicans infections and modulate macrophages phagocytosis of the fungus. Front Immunol, 9: 2829.
Diez-Orejas, R., Feito, M.J., Cicuéndez, M., Casarrubios, L., Rojo, J.M. & Portolés, M.T. (2018). Graphene oxide nanosheets increase Candida albicans killing by pro-inflammatory and reparative peritoneal macrophages. Biointerfaces Colloids Surf B, 171:250-59.
Dorko, E., Baranová, Z., Jenca, A., Kizek, P., Pilipcinec, E. & Tkáciková, L. (2005). Diabetes mellitus and candidiases. Folia Microbiol, 50:255-261.
Eba, M., Njunda, A.L., Mouliom, R.N., Kwenti, E.T., Fuh, A.N., Nchanji, G.T. & Atashili, J. (2016). Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns. BMC Res Notes, 9:1-8.
Erraji, H., Bahtaoui, W., Hali, F., Baline, K., Abdellaoui, M.S., & Chiheb, S. (2020). Paroniquias chroniques et Candida: étude descriptive et analytique de 164 cases. Ann Dermatol Venereol, 147:143-46.
Foss, N.T., Polon, D.P., Takada, M.H., Foss-Freitas, M.C. & Foss, M.C. (2005). Dermatoses em pacientes com diabetes mellitus. Rev Saúde Pública, 39:1-5.
Galletti J., Negri, M., Grassi, F.L., Kioshima-Cotica, E.S, & Svidzinski TIE. (2015). Fusarium spp. is able to grow and invade healthy human nails as a single source of nutrients. Eur J Clin Microbiol Infect Dis, 34:1767-72.
Gross, J.L., Silveiro, S.P., Camargo, J.L., Reichelt, A.J. & de Azevedo, M.J. (2002). Diabetes Melito: Diagnóstico, Classificação e Avaliação do Controle Glicêmico. Arq Bras Endocrinol Metab, 46:16-26.
Gupta, A.K., Versteeg, S.G. & Shear, N.H. (2017). Onychomycosis in the 21st Century: An update on diagnosis, epidemiology, and treatment. J Cutan Med Surg, 21:525-39.
Iser, B.P.M., Stopa, S.R., Chueiri, P.S., Szwarcwald, C.L., Malta, D.C., Monteiro, H.O.C., Duncan, B.B. & Schmidt, M.I. (2015). Self reported diabetes prevalence in Brazil: results from National Health Survey 2013. Prevalência de diabetes autorreferida en Brasil: resultados de la Encuesta Nacional de Salud 2013. Epidemiol Serv Saúde, 24:305-314.
Larone, D.H. Medically Important Fungi: A Guide to Identification. 5th ed. ASM Press, Washington, DC 2011
Lavery, L.A., Oz, O.K., Bhavan, K. & Wukich, D.K. (2019). Diabetic Foot Syndrome in the Twenty-First Century. Clin Podiatr Med Surg, 36:355-359.
Lima, A.L., Illing, T., Schliemann, S. & Elsner, P. (2017). Cutaneous manifestations of Diabetes Mellitus: A Review. Am J Clin Dermatol, 18: 541–553.
Lipner, S.R. & Scher, R.K. (2019). Part I: Onychomycosis: Clinical Overview and Diagnosis. J Am Acad Dermatol, 80: 835-835.
Mader, J.K., Haas, W., Aberer, F., Boulgaropoulos, B., Baumann, P., Pandis, M., Horvath, K., Aziz, K., Köhler, G., Pieber, T.R., Plank, J. & Sourij, H. (2019). Patients with healed diabetic foot ulcer represent a cohort at highest risk for future fatal events. Sci Rep, 9:10325.
Nenoff, P., Krüger, C., Ginter-Haselmayer, G. & Tietz, H.J. (2014). Mycology - an update. Part 1: Dermatomycoses: Causative agents, epidemiology and pathogenesis. J Dtsch Dermatol Ges, 12(3);188–210.
Normand, A.C., Becker, P., Gabriel, F., Cassagne, C., Accoceberry. I., Gari-Toussaint, M.L. et al. (2017). Validation of a new web application for identification of fungi by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol, 55:2661-2670.
Öztürk, A.M., Taşbakan, M., Metin, D.Y., Yener, C., Uysal, S., Şımşır, I.Y., Ertam, I., Pullukçu, H., Arda, B. & Çetinkalp, S. (2019). A neglected causative agent in diabetic foot infection: a retrospective evaluation of 13 patients with fungal etiology. Turk J Med Sci, 49:81-6.
Oz, Y., Goraan, I., Oz, A. & Balta, I. (2017). Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey. Int J Dermatol, 56:68-74.
Pai, Y.W., Lin, C.H., Lee, I.T. & Chang, M.H. (2018). Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus. Diabetes Metab Syndr, 12:111-116.
Poradzka, A., Jasik, M., Karnafel, W. & Fiedor, P. (2013). Clinical aspects of fungal infections in diabetes. Acta Pol Pharm, 70:587-596.
Salazar-Tamayo, G., López-Jácome, L.E., Resendiz-Sanchez, J., Franco-Cendejas, R., Rodriguez-Zulueta, P. & Corzo-León, D. E. (2017). Higher in vitro proliferation rate of Rhizopus oryzae in blood of diabetic individuals in chronic glycaemic control compared with non-diabetic individuals. Mycopathologia, 182:1005-1014.
Sanches, M.M., Roda, A., Pimenta, R., Filipe, P.L., & Freitas, J.P. (2019). Manifestações cutâneas da diabetes mellitus e pré-diabetes. Acta Med Port. 32:459–465.
Sultana, S., Jaigirdar, Q.H., Islam, M.A. & Azad, A.K. (2018). Frequency of fungal species of onychomycosis between diabetic and non-diabetic patients. Mymensingh Med J, 27:752-756.
Syzon, О.О., Turkevych, S.A., Rudnyk, T.I., Volbyn, S.V. & Dashko, M.O. (2019). Superficial candidosis course in patients with carbohydrate metabolism disorder and diabetes mellitus. Wiad Lek, 72:68-71.
Torres, T.B., Izaola, J.O. & De Luis, R.D.A. (2017). Abordaje nutricional del paciente con diabetes mellitus e insuficiencia renal crónica, a propósito de un caso. Nutr Hosp, 34:18-37.
Varon, A.G., Nouer, S.A., Barreiros, G., Trope, B.M., Magalhães, F., Akiti, T., Garnica, M. & Nucci, M. (2014). Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis. J Infect, 68:85-89.
Veiga, F.F., de Castro-Hoshino, L.V., Sato, F., Bombassaro, A., Vicente, V.A., Mendes, V., Baesso, M.L., Negri, M. & Svidzinski, T.I.E. (2018). Fusarium oxysporum is an onychomycosis etiopathogenic agent. Future Microbiol, 13:1745-1756.
Xiao, Z., Zhang, X., Geng, L., Zhang, F., Wu, J., Tong, J., Ogunbona, P.O. & Shan, C. (2017). Automatic non-proliferative diabetic retinopathy screening system based on color fundus image. Biomed Eng Online, ;16:122.
Wang, Y., O’Neil, A., Jiao, Y., Wang, L., Huang, J., Lan, Y., Zhu, Y. & Yu, C. (2019). Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants. BMC Med. 17:136.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Waylla Albuquerque de Jesus; Camila Barros Galinari; Glaucia Sayuri Arita; Valéria Aparecida Baquetti Mosca; Patrícia de Souza Bonfim-Mendonça; Terezinha Inez Estivalet Svidzinski
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
